Juan Pablo Villanueva-Cabezas

Dr. Juan Pablo Villanueva-Cabezas

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2022 in The Lancet Planetary Health
Verified
Journal Article
Open access
JVJuan Pablo Villanueva-Cabezas
Juan Pablo Villanueva-Cabezas
KWKenneth D Winkel
Kenneth D Winkel
PCPatricia T Campbell
Patricia T Campbell
AWAnke Wiethoelter
Anke Wiethoelter
CPCaitlin Pfeiffer
Caitlin Pfeiffer

12 August 2020 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
PDF file
JVJuan Pablo Villanueva-Cabezas
Juan Pablo Villanueva-Cabezas
ARArjun Rajkhowa
Arjun Rajkhowa
Angus CampbellAngus Campbell
Angus Campbell
The unprecedented pandemic events that currently affect animals and humans have fueled calls for One Health action. We argue that the One Health framework must be accompanied by ‘rich outcomes’ to avoid a reductionist One Health focus on zoonotic pathogens, that forgoes the benefits of the framework. We propose that the United Nation’s sustainable development goals provide an adequate multidimensional set of targets that can help researchers and policymakers contextualise emerging diseases, and guide One Health long‐term solutions that are equitable, efficacious, and sustainable.

1 September 2017 in Vaccine
Verified
Journal Article
Closed access
JVJuan Pablo Villanueva-Cabezas
Juan Pablo Villanueva-Cabezas
MCMauricio J.C. Coppo
Mauricio J.C. Coppo
PDPeter Durr
Peter Durr
JMJodie McVernon
Jodie McVernon

16 June 2022 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
HLHannah C Lewis
Hannah C Lewis
AMAdrian J. Marcato
Adrian J. Marcato
NMNiamh Meagher
Niamh Meagher
MVMarta Valenciano
Marta Valenciano
JVJuan Pablo Villanueva-Cabezas
Juan Pablo Villanueva-Cabezas
TGthe Unity Studies Collaborator Group
the Unity Studies Collaborator Group
We aimed to estimate the household secondary infection attack rate (hSAR) of SARS‐CoV‐2 in investigations aligned with the WHO Unity Studies Household Transmission Investigations (HHTI) protocol. We conducted a systematic review and meta‐analysis according to PRISMA 2020 guidelines. We searched Medline, Embase, Web of Science, Scopus and medRxiv/bioRxiv for “Unity‐aligned” First Few X cases (FFX) and HHTIs published 1 December 2019 to 26 July 2021. Standardised early results were shared by WHO Unity Studies collaborators (to 1 October 2021). We used a bespoke tool to assess investigation methodological quality. Values for hSAR and 95% confidence intervals (CIs) were extracted or calculated from crude data. Heterogeneity was assessed by visually inspecting overlap of CIs on forest plots and quantified in meta‐analyses. Of 9988 records retrieved, 80 articles (64 from databases; 16 provided by Unity Studies collaborators) were retained in the systematic review; 62 were included in the primary meta‐analysis. hSAR point estimates ranged from 2% to 90% (95% prediction interval: 3%–71%; I2 = 99.7%); I2 values remained >99% in subgroup analyses, indicating high, unexplained heterogeneity and leading to a decision not to report pooled hSAR estimates. FFX and HHTI remain critical epidemiological tools for early and ongoing characterisation of novel infectious pathogens. The large, unexplained variance in hSAR estimates emphasises the need to further support standardisation in planning, conduct and analysis, and for clear and comprehensive reporting of FFX and HHTIs in time and place, to guide evidence‐based pandemic preparedness and response efforts for SARS‐CoV‐2, influenza and future novel respiratory viruses.

6 February 2023 in Animals
Verified
Journal Article
Open access
PDF file
VLVan Phan Le
Van Phan Le
LNLan Thi Nguyen
Lan Thi Nguyen
JCJose Tobias Canevari
Jose Tobias Canevari
JVJuan Pablo Villanueva-Cabezas
Juan Pablo Villanueva-Cabezas
PPPawin Padungtod
Pawin Padungtod
MSMark A. Stevenson
Mark A. Stevenson
We describe results from a panel study in which pigs from a 17-sow African swine fever (ASF) positive herd in Thái Bình province, Vietnam, were followed over time to record the date of onset of ASF signs and the date of death from ASF. Our objectives were to (1) fit a susceptible-exposed-infectious-removed disease model to the data with transmission coefficients estimated using approximate Bayesian computation; (2) provide commentary on how a model of this type might be used to provide decision support for disease control authorities. For the outbreak in this herd, the median of the average latent period was 10 days (95% HPD (highest posterior density interval): 2 to 19 days), and the median of the average duration of infectiousness was 3 days (95% HPD: 2 to 4 days). The estimated median for the transmission coefficient was 3.3 (95% HPD: 0.4 to 8.9) infectious contacts per ASF-infectious pig per day. The estimated median for the basic reproductive number, R0, was 10 (95% HPD: 1.1 to 30). Our estimates of the basic reproductive number R0 were greater than estimates of R0 for ASF reported previously. The results presented in this study may be used to estimate the number of pigs expected to be showing clinical signs at a given number of days following an estimated incursion date. This will allow sample size calculations, with or without adjustment to account for less than perfect sensitivity of clinical examination, to be used to determine the appropriate number of pigs to examine to detect at least one with the disease. A second use of the results of this study would be to inform the equation-based within-herd spread components of stochastic agent-based and hybrid simulation models of ASF.

14 August 2024 in Preventive Veterinary Medicine
Verified
Journal Article
Open access
AZAbigail Van Der Zwan
Abigail Van Der Zwan
PCPatricia T. Campbell
Patricia T. Campbell
NSNancy Shi
Nancy Shi
NBNikita De Bortoli
Nikita De Bortoli
JVJuan Pablo Villanueva-Cabezas
Juan Pablo Villanueva-Cabezas
Bovine Tuberculosis (bTB), caused by Mycobacterium bovis, is a neglected zoonotic disease primarily associated with cattle. The incidence of bTB is highest in low-income settings with high cattle density and unpasteurised dairy consumption. Smallholder dairy farming has steadily grown in low- and middle-income countries (LMICs) with limited professional support for adequate bTB surveillance and risk mitigation. Several studies have explored the knowledge, attitudes, and practices (KAP) of milk value chain stakeholders towards bTB in LMICs, but this evidence has not been collated and synthesised. We conducted a systematic review to determine what is known, believed, and done in relation to bTB among dairy producers and consumers in LMICs. We performed a systematic search of studies in OVID Medline, Scopus and CABI on 11 September 2023. KAP data were summarised using narrative synthesis and forest plots. We retrieved 2763 articles, retaining 51 for the review. Only studies from Africa (n = 38) and Asia (n = 13) met the eligibility criteria. Most populations reported awareness of human tuberculosis and knew it could be treated, but there was limited awareness of bTB and its zoonotic potential. Knowledge of bTB transmission routes and bTB mitigation varied across populations, and risky practices were also variable. Inconsistencies in study design and survey tools suggest some results may have a mid- to high-risk of bias. Awareness of bTB is surprisingly low among African and Asian populations with high bTB exposure risk, possibly due to the long-standing divide between animal and human health messages that has obscured the One Health implications of bTB. Addressing bTB in LMICs requires a structural One Health approach and standard KAP survey tools to adequately explore the socio-cultural, political, and economic processes and drivers favouring bTB spread and persistence.